Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,870 signal articles · 236 in last 24h · 118,518 total before filter · latest 57m ago
236last 24h
1535last 7d
251● bullish (7d)
161● bearish (7d)
205publishers
AllMacro296Earnings618M&A99Regulatory24Product14Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions
StockStory91d agoneutral
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

Halozyme Therapeutics’ first quarter results for 2026 were met with a positive market response, underpinned by substantial royalty revenue growth and the expanding adoption of subcutaneous drug delivery through its ENHANZE technology. CEO Helen Torley credited the quarter’s momentum to broader use of key partner products such as DARZALEX, VYVGART Hytrulo, and PHESGO, with royalty streams up 43% year-over-year. The company also benefited from ramping contributions from recently launched therapies

CAVA Group Q1 Earnings Call Highlights
MarketBeat91d agoneutral
CAVA Group Q1 Earnings Call Highlights

CAVA Group (NYSE:CAVA) reported strong first-quarter 2026 results, with executives pointing to traffic gains, new restaurant performance and continued demand for Mediterranean cuisine as key drivers of growth. On the company’s earnings call, Co-Founder and CEO Brett Schulman said CAVA “further soli

Cava (CAVA) Q1 2026 Earnings Call Transcript
Motley Fool91d agoneutral
Cava (CAVA) Q1 2026 Earnings Call Transcript

All forward looking statements are made as of today, and except as required by law, CAVA undertakes no obligation to publicly update or revise any forward looking statement. In the 2026, we further solidified our position as the clear leader in the Mediterranean cuisine category.

Keysight (KEYS) Beats Q2 Earnings Estimates
Zacks91d agobullish
Keysight (KEYS) Beats Q2 Earnings Estimates

Keysight (KEYS) delivered earnings and revenue surprises of +23.18% and -0.07%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Keysight Technologies Q2 Earnings Call Highlights
MarketBeat91d agoneutral
Keysight Technologies Q2 Earnings Call Highlights

Keysight Technologies (NYSE:KEYS) reported what executives described as the best quarter in the company’s history, with fiscal second-quarter orders surpassing $2 billion and revenue rising sharply across its communications and electronic industrial businesses. President and CEO Satish Dhanasekaran

Keysight (KEYS) Q2 2026 Earnings Transcript
Motley Fool91d agoneutral
Keysight (KEYS) Q2 2026 Earnings Transcript

Satish Dhanasekaran, president and CEO Neil Dougherty, executive vice president and CFO Kailash Narayanan, president of the Communication Solutions Group, Jason Carey, president of the Electronic Industrial Solutions Group, and Sung J. Yoon, senior vice president of global sales. Following the prepared remarks from Satish and Neil, we will take your questions.

Investing.com91d agobullish
Cava stock rises on earnings beat and raised guidance

Investing.com -- CAVA Group Inc (NYSE:CAVA) reported first quarter results that exceeded analyst expectations, driving shares up over 6% in after-hours trading Tuesday as the Mediterranean fast-casual chain raised its full-year outlook.

Gemini Space (GEMI) Q1 2026 Earnings Call Transcript
Motley Fool91d agoneutral
Gemini Space (GEMI) Q1 2026 Earnings Call Transcript

This quarter, we grew revenue 42% and transaction revenue held steady year-over-year, even as trading volume declined more than 50% due to softness in the broader crypto market. The price of Bitcoin is down roughly 30% since our IPO, and we are tied to that cycle.